Global Catheters Market Expected to Reach USD 51.65 Billion by 2033
Rising chronic diseases, technological advancements, and minimally invasive procedures drive the growth of the global catheter market.
According to Renub Research Latest Report catheters market is projected to grow from USD 25.32 billion in 2024 to USD 51.65 billion by 2033, registering a compound annual growth rate (CAGR) of 8.24% between 2025 and 2033. This growth is fueled by the rising prevalence of chronic diseases, increasing demand for advanced healthcare services, technological innovations in catheter devices, and a growing elderly population.
Catheters are versatile medical devices introduced into the body to drain fluids, deliver medications, monitor physiological conditions, or assist in various diagnostic procedures. Typically made of silicone, rubber, or plastic, catheters are widely used in urology, cardiology, dialysis, surgery, and chemotherapy. Their ability to facilitate precise, minimally invasive procedures has made them indispensable in modern medicine.
Market Overview
Catheters play a critical role in urinary drainage for patients with retention or post-surgical care, cardiovascular interventions such as drug delivery and diagnostic tests, hemodialysis treatments, and fluid administration during surgery. Their widespread applications contribute to improved patient outcomes, quicker recovery, and reduced procedural complications.
Globally, the prevalence of chronic diseases such as cardiovascular disorders, diabetes, kidney failure, and cancer is increasing. According to the World Health Organization, approximately 18 million people die annually from cardiovascular diseases, 9 million from cancers, 4 million from chronic respiratory diseases, and 2 million from diabetes. Such trends are significantly driving demand for catheter-based interventions and treatments.
Growth Drivers of the Catheter Market
1. Increasing Incidence of Chronic Diseases
Chronic conditions require ongoing medical management, often involving catheter-based procedures like dialysis catheterization, blood pressure monitoring, and drug delivery. The aging global population and higher chronic disease prevalence are pushing the demand for continuous and long-term catheter use. The increasing need for safe and efficient medical procedures makes catheters essential in both hospital and home-care settings.
2. Catheter Technology Advancements
Technological innovations have revolutionized catheter design. Modern catheters are now flexible, durable, minimally invasive, and equipped with infection-resistant coatings. Bioabsorbable catheters, advanced materials, and precision-engineered designs reduce patient recovery time, minimize complications, and enhance treatment efficiency.
For instance, in September 2024, the EMBOGUARD™ Balloon Guide Catheter optimized clot removal during mechanical thrombectomy (MT) procedures, enhancing recanalization success and reducing procedural risks. Innovations like this demonstrate the industry’s focus on improving patient safety and clinical outcomes, driving global demand.
3. Rising Demand for Minimally Invasive Procedures
Minimally invasive surgeries, characterized by smaller incisions, faster recovery, and reduced complications, increasingly rely on catheters for fluid drainage, drug delivery, and diagnostics. Hospitals and patients are opting for safer, more efficient procedures, fueling catheter adoption across surgical specialties. In the U.S., 26.2 million surgical procedures were performed in 2023, many of which utilize catheter technologies, reflecting the growing preference for minimally invasive interventions.
Regional Market Insights
Germany
Germany holds a significant share in the European catheter market due to its robust healthcare system, advanced medical technologies, and an aging population. High adoption of infection-resistant catheters and ongoing R&D in medical devices enhance patient outcomes. In June 2023, Biotronik introduced its Oscar multifunctional peripheral catheter at LINC, demonstrating Germany’s leadership in innovation and catheter adoption.
China
China’s catheter market is expanding rapidly, driven by government investments in healthcare infrastructure and increased awareness of chronic disease management. Rising incidences of diabetes, cardiovascular diseases, and kidney disorders propel catheter demand. Domestic manufacturing of low-cost, advanced technology catheters, including antimicrobial-coated products, ensures stable local supply and export potential. In August 2023, China approved the Novasight dual-mode intravascular imaging catheter, highlighting rapid adoption of innovative devices.
Brazil
As the largest catheter market in Latin America, Brazil’s growth is driven by expanding healthcare infrastructure, rising chronic disease prevalence, and growing awareness of minimally invasive procedures. In September 2023, Endovastec successfully implanted the Reewarm™ PTX Drug-Coated Balloon (DCB) Catheter, strengthening Brazil’s international presence in catheter technologies.
United Arab Emirates
The UAE is a key market in the Middle East due to investments in advanced healthcare infrastructure, high demand for minimally invasive treatments, and a focus on medical tourism. Lifestyle-related chronic diseases like diabetes and cardiovascular conditions increase catheter utilization. In February 2024, Zylox-Tonbridge received market approval for five medical devices, highlighting rapid adoption in the UAE.
South Africa
South Africa leads the African catheter market, supported by growing chronic disease prevalence, healthcare infrastructure improvements, and increased awareness of advanced medical devices. Innovative catheter designs, improved accessibility, and expanded distribution networks help address gaps in care. Coloplast’s intermittent catheter for urinary tract infection reduction (available since November 2022) exemplifies the region’s focus on safer, patient-friendly solutions.
By Type:
TAVR (Transcatheter Aortic Valve Replacement)
TMVR (Transcatheter Mitral Valve Replacement)
TPVR (Transcatheter Pulmonary Valve Replacement)
By Material:
Mechanical tissue
Biological tissue
By End-User:
Hospitals
Ambulatory surgical centers
Others
By Product Approach:
Transfemoral
Transapical
Transaortic
Others
By Application:
Aortic Stenosis
Aortic Regurgitation
Others
By Region:
North America: United States, Canada
Europe: France, Germany, Italy, Spain, UK, Belgium, Netherlands, Turkey
Asia-Pacific: China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand
Latin America: Brazil, Mexico, Argentina
Middle East & Africa: Saudi Arabia, UAE, South Africa
Key Players and Company Insights
Abbott Laboratories
FDA approvals in February 2023 for Sensor EnabledTM TactiFlex Ablation Catheter and FlexAbility Ablation Catheter for complex cardiac conditions.
The Amulet™ LAA Occluder demonstrated high efficacy in atrial fibrillation treatment compared to Boston Scientific’s Watchman device.
Becton Dickinson and Company (BD)
Introduced BD PosiFlushSafeScrub, a prefilled syringe to reduce CRBSIs.
Developed an ultrasound system to improve vascular access procedures.
Conducted first peer-reviewed study on midline catheters for blood collection.
Boston Scientific Corporation
Acquired China-based Acotec Scientific Holdings for expertise in drug-coated balloons and thrombus aspiration catheters (Dec 2022).
FDA approved FARAPULSE™ Pulsed Field Ablation (PFA) System in January 2024.
FDA clearance for AGENT™ Drug-Coated Balloon in March 2024.
Teleflex Incorporated
Triumph Catheter approved by FDA in Feb 2023 for accurate wire navigation.
Introduced NaviCurve™ Stylet and Arrow® VPS Rhythm® DLX for PICC improvements (May 2023).
Medtronic Plc.
FDA approvals for FreezorXtra Cardiac Cryoablation Catheters in February 2022.
PulseSelect Pulsed Field Ablation System approved in December 2023.
CE Mark for Affera™ Mapping and Ablation System in March 2023.
Johnson & Johnson MedTech
Acquired Laminar, Inc. in November 2023 for enhanced cardiac arrhythmia solutions.
CE mark clearance for VARIPULSE™ Platform in February 2024 for paroxysmal AF treatment.
Edwards Lifesciences Corporation
FDA approval for EVOQUE transcatheter therapy in February 2024 for tricuspid regurgitation.
Presented long-term data from COMMENCE study demonstrating minimal bioprosthetic valve degradation.
Stryker Corporation
Launched ExcelsiusGPS surgical guidance system in August 2023, enabling faster and autonomous catheter placement.
Opened Keystone Suite Neurovascular Lab in Gurgaon, India (Dec 2022).
Future Outlook
The global catheter market is expected to grow strongly due to:
Increasing prevalence of chronic diseases
Technological advancements in catheter design, materials, and coatings
Rising preference for minimally invasive procedures
Expansion of healthcare infrastructure in emerging markets
Increasing adoption of innovative, patient-friendly devices
Despite challenges such as high costs and regulatory hurdles, ongoing innovations and government healthcare initiatives are creating greater accessibility and adoption. Hospitals, ambulatory surgical centers, and home-care providers will continue to be pivotal in driving catheter market growth globally.
Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.
About the Creator
Janine Root
Janine Root is a skilled content writer with a passion for creating engaging, informative, and SEO-optimized content. She excels in crafting compelling narratives that resonate with audiences and drive results.
Keep reading
More stories from Janine Root and writers in Journal and other communities.
Global Carmine Market Forecast to Reach USD 85.40 Million by 2033
According to Renub Research Latest Report carmine market is projected to grow from USD 48.62 million in 2024 to USD 85.40 million by 2033, exhibiting a compound annual growth rate (CAGR) of 6.40%. The surge in consumer preference for natural food colorants and the broadening applications of carmine across the food, beverage, cosmetics, and pharmaceutical industries are the primary drivers of this expansion.
By Janine Root 4 months ago in Journal
The goals I did not achieve
Every writing goal I made for the year is a wash. It has been this way for a while, but I think it's important to be open about my failures and the reality of how life can get in the way. This is especially true considering the several times I have posted on Vocal about my writing goals, how I was changing my approach, and where I was hoping to be for the upcoming year. I will probably do that again in a couple months, but for now, it is time to acknowledge where I am today.
By Kay Husnick23 days ago in Journal
Indian weapons must on all 114 Rafale jets, govt tells Dassault
India’s defense modernization plans received a strategic boost as the government officially directed Dassault Aviation, the French manufacturer of Rafale fighter jets, to equip all 114 aircraft with Indian-made weapons. This move underlines India’s commitment to self-reliance in defense technology while strengthening the combat readiness of its air force. The Rafale jets, considered among the most advanced multi-role fighters globally, are now set to carry the nation’s indigenous missile systems, bombs, and electronic warfare packages, blending cutting-edge French airframe technology with homegrown armaments. The Rafale Program and Indigenous Weapons India’s Rafale acquisition, initially contracted in 2016, brought 36 jets into the Air Force inventory, with an additional 114 aircraft to be delivered in subsequent batches. While Dassault’s jets are equipped with state-of-the-art French systems, the Indian government has long emphasized the integration of locally produced weapons. These include BrahMos supersonic cruise missiles, Astra beyond-visual-range air-to-air missiles, and indigenous precision-guided bombs. By mandating the use of Indian weapons across all 114 Rafales, the government aims to reduce dependency on foreign arms supplies and ensure that India’s air force maintains operational flexibility in critical combat scenarios. A senior defense official stated, “Our aim is to ensure that the Rafale platform not only brings in technological superiority but also becomes a force multiplier for our indigenous weapons programs.” Strategic Implications The integration of Indian weapons on Rafale jets carries both operational and strategic significance. From an operational perspective, using indigenous weapons allows for standardized maintenance and training protocols across the fleet. It simplifies logistics, reduces costs, and ensures that India is not constrained by export restrictions or supply chain uncertainties from foreign manufacturers. Strategically, the decision sends a strong signal to both allies and adversaries. India demonstrates its growing capability in defense production and its intention to assert technological independence in critical military domains. Given the geopolitical tensions in the Indo-Pacific, particularly with China and Pakistan, equipping the Rafales with locally produced weapons enhances India’s deterrence posture. Challenges in Integration Integrating indigenous weapons with Rafale aircraft, however, is not without technical challenges. Aircraft and weapons systems must be seamlessly compatible, including software integration, aerodynamics, and avionics. The Air Force’s testing and evaluation teams, along with Dassault engineers, will have to ensure that Indian missiles, bombs, and sensors work flawlessly with French-designed flight systems. Past collaborations, such as integrating the BrahMos missile on Su-30MKI aircraft, offer a blueprint for success, but the Rafale’s advanced avionics and fly-by-wire systems necessitate meticulous engineering and rigorous testing. Officials assure that phased testing and gradual integration will ensure minimal disruption to the aircraft’s delivery schedules. Boosting India’s Defense Industry This directive aligns closely with India’s “Make in India” initiative, which aims to build a robust domestic defense manufacturing ecosystem. By mandating the use of Indian weapons, the government hopes to create opportunities for local defense firms, enhance research and development capabilities, and encourage private sector participation in high-tech defense projects. According to industry experts, this approach will provide a significant boost to companies involved in missile development, precision-guided munitions, and electronic warfare systems. It also signals potential for future export opportunities, as Rafale jets equipped with Indian weapons could be offered to other countries, increasing India’s global defense footprint. Diplomatic and Industrial Balance While this move strengthens India’s self-reliance, it also requires careful diplomatic balancing. Dassault Aviation, which must now adapt its jets to accommodate Indian weapons, plays a critical role in maintaining delivery timelines and contractual obligations. Successful collaboration will require constant communication and technical coordination between French and Indian engineers. In the long term, this partnership could evolve into a model for international collaboration, where global platforms are paired with indigenous systems to create hybrid solutions tailored to specific national needs. Looking Ahead India’s decision to equip all Rafale jets with local weapons is a bold step toward achieving strategic autonomy in defense. It demonstrates the country’s commitment to blending cutting-edge technology with self-reliance, ensuring that the Air Force is equipped with a versatile, powerful, and locally sustainable arsenal. As the delivery of Rafale jets continues, the coming years will likely see a seamless integration of India’s missiles, bombs, and electronic warfare systems into the fleet, creating a formidable air power platform that combines the best of French aeronautical engineering with India’s indigenous defense innovation. This initiative not only strengthens India’s air defense capabilities but also reinforces its position as a rising power in global defense technology. It’s a reminder that modern warfare increasingly depends on the ability to combine advanced platforms with locally developed systems—a strategy India is now executing with clarity and purpose.
By Fiaz Ahmed Brohi2 days ago in Journal
So You Decided To Become a Nurse Practitioner:
So you decided to become an "Advanced Practice" nurse. Congratulations!... is what I would say if this was a good idea. Grad school? In this economy? What were you thinking? Likely it was something along the lines of either 1) “I've seen these other chucklefucks do it— Why can't I?” or even 2) “I've got a nice career, I should shake it up. I miss feeling like I have no clue what I'm doing.”
By Sandor Szaboa day ago in Fiction
Comments
There are no comments for this story
Be the first to respond and start the conversation.